Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on July 26, 2024

CRISPR Therapeutics Nears 52-Week Low. Time to Buy?

TipRanks

2 days ago

CRISPR Therapeutics Nears 52-Week Low. Time to Buy?

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Zacks

3 days ago

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?

Zacks

3 days ago

Is a Beat in the Cards for CRISPR (CRSP) in Q2 Earnings?

3 Monster Stocks in the Making to Buy Right Now

Motley Fool

7 days ago

3 Monster Stocks in the Making to Buy Right Now

Institutional investors must be pleased after a 8.9% gain last week that adds to CRISPR Therapeutics AG's (NASDAQ:CRSP) one-year returns

Simply Wall St.

8 days ago

Institutional investors must be pleased after a 8.9% gain last week that adds to CRISPR Therapeutics AG's (NASDAQ:CRSP) one-year returns

CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?

Zacks

10 days ago

CRISPR Therapeutics (CRSP) Moves 9.2% Higher: Will This Strength Last?

Dow, S&P 500 rally on strong retail data, gold reaches record high: Yahoo Finance

Yahoo Finance Video

10 days ago

Dow, S&P 500 rally on strong retail data, gold reaches record high: Yahoo Finance

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

11 days ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

Motley Fool

15 days ago

1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market Today

Zacks

16 days ago

Here's Why CRISPR Therapeutics AG (CRSP) Gained But Lagged the Market Today

Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years?

Insider Monkey

25 days ago

Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years?

Morningstar Research

a month ago

Analyst Report: CRISPR Therapeutics AG

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."

Motley Fool

a month ago

Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?

Zacks

a month ago

Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?

TipRanks

a month ago

CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

Morningstar Research

a month ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

2 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

2 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

2 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

Motley Fool

2 months ago

Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?

Zacks

2 months ago

Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?

Cathie Wood Invests In 2 Biotechnology Stocks – Are They Worth Buying?

Benzinga

2 months ago

Cathie Wood Invests In 2 Biotechnology Stocks – Are They Worth Buying?

Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?

Motley Fool

2 months ago

Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow

Motley Fool

2 months ago

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow

MT Newswires

2 months ago

CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

GlobeNewswire

2 months ago

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

Is CRISPR Therapeutics a Millionaire Maker?

Motley Fool

2 months ago

Is CRISPR Therapeutics a Millionaire Maker?

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Motley Fool

2 months ago

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?

TipRanks

2 months ago

BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?

Is CRISPR Therapeutics Stock a Buy?

Motley Fool

2 months ago

Is CRISPR Therapeutics Stock a Buy?

Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.

Motley Fool

2 months ago

Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.

2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

Motley Fool

2 months ago

2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

15 Best ARK Stocks To Buy Now

Insider Monkey

2 months ago

15 Best ARK Stocks To Buy Now

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher

Simply Wall St.

3 months ago

Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher

GuruFocus.com

3 months ago

CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast

MT Newswires

3 months ago

Oppenheimer Adjusts CRISPR Therapeutics Price Target to $95 From $102, Maintains Outperform Rating

We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow

Simply Wall St.

3 months ago

We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow

MT Newswires

3 months ago

Barclays Adjusts Price Target on CRISPR Therapeutics to $67 From $80, Maintains Equal-Weight Rating

MT Newswires

3 months ago

Needham Adjusts Price Target on CRISPR Therapeutics to $88 From $90, Keeps Buy Rating

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

Zacks

3 months ago

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

MT Newswires

3 months ago

Baird Adjusts Price Target on CRISPR Therapeutics to $52 From $46, Keeps Neutral Rating

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

Morningstar Research

3 months ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

GlobeNewswire

3 months ago

CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

Zacks

3 months ago

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond

Motley Fool

3 months ago

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

Zacks

3 months ago

Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock

CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note

Reuters

3 months ago

Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks

Insider Monkey

3 months ago

Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks

CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact

TipRanks

3 months ago

CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact

ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential

Insider Monkey

3 months ago

ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential

Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?

Zacks

3 months ago

Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years

Simply Wall St.

3 months ago

CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

3 months ago

3 Magnificent Stocks That Could Double or More by 2030

Charles River (CRL) Forges Collaboration With Ship of Theseus

Zacks

3 months ago

Charles River (CRL) Forges Collaboration With Ship of Theseus

Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance

ETF Trends

4 months ago

Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance

CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider

Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics

Motley Fool

4 months ago

Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

Motley Fool

4 months ago

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know

CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

GlobeNewswire

4 months ago

CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

3 Unstoppable Stocks to Buy Hand Over Fist in April

Motley Fool

4 months ago

3 Unstoppable Stocks to Buy Hand Over Fist in April

3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000

Motley Fool

4 months ago

3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Cathie Wood’s Stock Portfolio: 2024 Stock Picks

Insider Monkey

4 months ago

Cathie Wood’s Stock Portfolio: 2024 Stock Picks

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Motley Fool

4 months ago

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know

Insider Sell: CFO Raju Prasad Sells Shares of CRISPR Therapeutics AG (CRSP)

GuruFocus.com

4 months ago

Insider Sell: CFO Raju Prasad Sells Shares of CRISPR Therapeutics AG (CRSP)

30 Biggest Biotechnology Companies in the World

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

Is It Too Late to Buy CRISPR Therapeutics Stock?

Motley Fool

4 months ago

Is It Too Late to Buy CRISPR Therapeutics Stock?

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

GlobeNewswire

4 months ago

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

A Look At The Fair Value Of CRISPR Therapeutics AG (NASDAQ:CRSP)

Simply Wall St.

5 months ago

A Look At The Fair Value Of CRISPR Therapeutics AG (NASDAQ:CRSP)

The Top 3 Biotech Stocks to Buy in March 2024

InvestorPlace

5 months ago

The Top 3 Biotech Stocks to Buy in March 2024

Here's Why CRISPR Therapeutics Stock Climbed 34% in February

Motley Fool

5 months ago

Here's Why CRISPR Therapeutics Stock Climbed 34% in February

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

InvestorPlace

5 months ago

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst

Motley Fool

5 months ago

CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst

A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now

Motley Fool

5 months ago

A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now

3 Biotech Stocks Bound to Blast Off By 2029

InvestorPlace

5 months ago

3 Biotech Stocks Bound to Blast Off By 2029

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Motley Fool

5 months ago

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Share on Social Networks: